Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122568) titled 'Mechanistic Investigation of Nanoplastics-Induced Hirschsprung's Disease via Methionine Metabolic Reprogramming and JAK/STAT Pathway Activation in Enteric Neurons' on April 15.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Affiliated Hospital of Zunyi Medical University
Condition:
Hirschsprung's disease
Intervention:
HSCR group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: HSCR group:30;Normal infants and young children (control group):30;
Countries of Recruitment:
China
To know more, visit https://www...